Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Yalcin

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Archives of Gynecology and Obstetrics|February 1, 2018
Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?Hanifi Sahin, Mustafa Erkan Sari, Zeliha Firat Cuylan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 28, 2025
Survival outcomes of sentinel lymph node biopsy alone versus back-up systematic lymph node dissection in high-risk endometrial Cancer: A Turkish Gynecologic Oncology group study (TRSGO-SLN-007)Ali Gokce, Salih Taskin, Dogan Vatansever, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2016
Surgical Treatment of Metastatic Ovarian Tumors From Extragenital Primary SitesVeysel Sal, Fuat Demirkiran, Samet Topuz, et al.
Journal of Ovarian Research|March 7, 2018
Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?Hanifi Sahin, Mehmet Mutlu Meydanli, Mustafa Erkan Sari, et al.
Journal of Surgical Oncology|December 1, 2020
Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004)Duygu Altin, Salih Taskin, Nedim Tokgozoglu, et al.
Journal of Clinical Medicine|December 30, 2025
Retrospective Multicenter Analysis of Malignant Struma Ovarii: Clinical Characteristics, Management, and OutcomesAtacem Mert Aytekin, Yagmur Arslan, Utku Akgor, et al.
Journal of Surgical Oncology|March 3, 2021
Impact of cytoreductive surgery on survival of patients with low-grade serous ovarian carcinoma: A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO-OvCa-001)Dogan Vatansever, Cagatay Taskiran, Mehmet Mutlu Meydanli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Risk factors for the involvement of sentinel lymph nodes in endometrial cancer (TRSGO-SLN-010)Ibrahim Yalcin, Salih Taskin, Ozguc Takmaz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2019
SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter studyIlker Kahramanoglu, Mehmet Mutlu Meydanli, Siarhei Taranenka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2025
Sentinel SENECA risk factors for unsuccessful bi-lateral sentinel lymph node mapping in endometrial cancerFélix Boria, Enrique Chacón, R Rajagopalan Iyer, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Archives of Gynecology and Obstetrics|February 1, 2018
Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?Hanifi Sahin, Mustafa Erkan Sari, Zeliha Firat Cuylan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 28, 2025
Survival outcomes of sentinel lymph node biopsy alone versus back-up systematic lymph node dissection in high-risk endometrial Cancer: A Turkish Gynecologic Oncology group study (TRSGO-SLN-007)Ali Gokce, Salih Taskin, Dogan Vatansever, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2016
Surgical Treatment of Metastatic Ovarian Tumors From Extragenital Primary SitesVeysel Sal, Fuat Demirkiran, Samet Topuz, et al.
Journal of Ovarian Research|March 7, 2018
Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?Hanifi Sahin, Mehmet Mutlu Meydanli, Mustafa Erkan Sari, et al.
Journal of Surgical Oncology|December 1, 2020
Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004)Duygu Altin, Salih Taskin, Nedim Tokgozoglu, et al.
Journal of Clinical Medicine|December 30, 2025
Retrospective Multicenter Analysis of Malignant Struma Ovarii: Clinical Characteristics, Management, and OutcomesAtacem Mert Aytekin, Yagmur Arslan, Utku Akgor, et al.
Journal of Surgical Oncology|March 3, 2021
Impact of cytoreductive surgery on survival of patients with low-grade serous ovarian carcinoma: A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO-OvCa-001)Dogan Vatansever, Cagatay Taskiran, Mehmet Mutlu Meydanli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Risk factors for the involvement of sentinel lymph nodes in endometrial cancer (TRSGO-SLN-010)Ibrahim Yalcin, Salih Taskin, Ozguc Takmaz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2019
SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter studyIlker Kahramanoglu, Mehmet Mutlu Meydanli, Siarhei Taranenka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2025
Sentinel SENECA risk factors for unsuccessful bi-lateral sentinel lymph node mapping in endometrial cancerFélix Boria, Enrique Chacón, R Rajagopalan Iyer, et al.
Pageof 3